DKNG vs SGMO · rev $4.77B vs rev $57.8M
DraftKings Inc (DKNG) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
DraftKings Inc (DKNG) is a gambling company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported DKNG revenue for 2024-12-31 was $4.77B. Net income was -$507.3M. Revenue was up 30.1% from 2023-12-31 to 2024-12-31. DKNG currently screens at market cap $20.96B.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
DKNG currently screens at market cap $20.96B. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the DKNG and SGMO stock pages for the full models.
Not investment advice.